LogoPressRelease.jpg
Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1
January 31, 2019 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a...
LogoPressRelease.jpg
Fluidigm Announces Third Quarter 2018 Financial Results
November 01, 2018 16:05 ET | Fluidigm Corporation
Total revenue increases 17 percent to $29.0 million Mass cytometry revenue growth of 50 percent Instrument revenue growth of 32 percent SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
October 01, 2018 16:15 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
LogoPressRelease.jpg
Fluidigm to Participate at Upcoming Investor Events in September
September 05, 2018 18:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...